 |
49 Diseases |  |
11 Trials |
|
11 Trials |  |
798 News |  |
| «12...234567891011121314 |
- | nimodipine microparticles (EG-1962) / PDS Biotech
Trial primary completion date: Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH (clinicaltrials.gov) - Jul 26, 2018
P1, N=6, Terminated, Sponsor: Edge Therapeutics Inc
Trial primary completion date: Mar 2018 --> Dec 2017
- | nimodipine / Generic mfg.
Trial completion: Nimodipine for Treating Acute Massive Cerebral Infarction (clinicaltrials.gov) - May 1, 2018
P4, N=72, Completed, Sponsor: Fengtian Hospital
Trial primary completion date: Mar 2018 --> Dec 2017 Recruiting --> Completed
- ||||| nimodipine microparticles (EG-1962) / PDS Biotech
Enrollment closed: NEWTON2: Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Apr 6, 2018
P3, N=374, Active, not recruiting, Sponsor: Edge Therapeutics Inc
Recruiting --> Completed Recruiting --> Active, not recruiting
- nimodipine microparticles (EG-1962) / PDS Biotech
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH (clinicaltrials.gov) - Apr 6, 2018
P1, N=6, Terminated, Sponsor: Edge Therapeutics Inc
Recruiting --> Active, not recruiting N=12 --> 6 | Trial completion date: Mar 2019 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Mar 2018; Based on DMC recommendation to discontinue EG-01-1962-03
- nimodipine microparticles (EG-1962) / PDS Biotech
Trial completion date, Trial primary completion date: Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH (clinicaltrials.gov) - Mar 1, 2018
P1, N=12, Recruiting, Sponsor: Edge Therapeutics Inc
N=12 --> 6 | Trial completion date: Mar 2019 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Mar 2018; Based on DMC recommendation to discontinue EG-01-1962-03 Trial primary completion date: Feb 2018 --> Mar 2019 | Trial completion date: Feb 2018 --> Mar 2019
- | nimodipine / Generic mfg., choline alfoscerate / Generic mfg.
New P2 trial: CONIVAD: Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment (clinicaltrials.gov) - Jul 25, 2017
P2, N=68, Recruiting, Sponsor: Azienda Ospedaliero-Universitaria Careggi
- | verapamil / Generic mfg., nimodipine / Generic mfg.
New P4 trial: RCVS: The Rational Approach to Diagnosis and Treatment (clinicaltrials.gov) - May 12, 2017
P4, N=40, Recruiting, Sponsor: Johns Hopkins University
- | nimodipine / Generic mfg.
Enrollment open: Noninvasive Assessment of Cerebral Oxygenation and Cardiac Function in Patients With Neurovascular Diseases (clinicaltrials.gov) - Mar 28, 2017
P=N/A, N=25, Recruiting, Sponsor: National Institute of Mental Health and Neuro Sciences, India
Trial primary completion date: Feb 2018 --> Mar 2019 | Trial completion date: Feb 2018 --> Mar 2019 Active, not recruiting --> Recruiting
- nimodipine microparticles (EG-1962) / PDS Biotech
Enrollment open: Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH (clinicaltrials.gov) - Jan 10, 2017
P1, N=12, Recruiting, Sponsor: Edge Therapeutics Inc
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- nimodipine / Generic mfg.
New trial: Noninvasive Assessment of Cerebral Oxygenation and Cardiac Function in Patients With Neurovascular Diseases (clinicaltrials.gov) - Dec 13, 2016
P=N/A, N=25, Active, not recruiting, Sponsor: National Institute of Mental Health and Neuro Sciences, India
- nimodipine / Generic mfg.
Enrollment change, Trial termination: The Effect of Nimodipine on the Postoperative Cognitive Dysfunction (clinicaltrials.gov) - Oct 18, 2016
P=N/A, N=15, Terminated, Sponsor: University Hospital Hradec Kralove
Not yet recruiting --> Recruiting N=50 --> 15 | Recruiting --> Terminated; higher POCD in nimodipine Group
- | nimodipine microparticles (EG-1962) / PDS Biotech
New P1 trial: Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH (clinicaltrials.gov) - Sep 9, 2016
P1, N=12, Not yet recruiting, Sponsor: Edge Therapeutics Inc
- |||||| nimodipine microparticles (EG-1962) / PDS Biotech
Enrollment open: NEWTON2: Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Aug 1, 2016
P3, N=374, Recruiting, Sponsor: Edge Therapeutics Inc
N=50 --> 15 | Recruiting --> Terminated; higher POCD in nimodipine Group Not yet recruiting --> Recruiting
- |||||||||| nimodipine microparticles (EG-1962) / PDS Biotech
New P3 trial: NEWTON2: Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Jun 9, 2016
P3, N=374, Not yet recruiting, Sponsor: Edge Therapeutics Inc
- nimodipine / Generic mfg.
Trial completion, Trial primary completion date: Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations (clinicaltrials.gov) - May 16, 2016
P1, N=8, Completed, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2016
- nimodipine / Generic mfg.
Enrollment change, Trial termination: Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) - May 6, 2016
P2, N=12, Terminated, Sponsor: Mount Sinai Hospital, Canada
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2016 N=90 --> 12 | Active, not recruiting --> Terminated; small number of patients got recruited
- |||| nimodipine microparticles (EG-1962) / PDS Biotech
Trial completion, Enrollment change, Trial primary completion date: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Jan 21, 2016
P1/2, N=73, Completed, Sponsor: Edge Therapeutics Inc
N=90 --> 12 | Active, not recruiting --> Terminated; small number of patients got recruited Active, not recruiting --> Completed | N=96 --> 73 | Trial primary completion date: Jul 2015 --> Jan 2016
- nimodipine / Generic mfg.
Trial completion: Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=22, Completed, Sponsor: Boston IVF
Active, not recruiting --> Completed | N=96 --> 73 | Trial primary completion date: Jul 2015 --> Jan 2016 Active, not recruiting --> Completed
- nimodipine / Generic mfg.
Trial termination, Trial primary completion date: Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression (clinicaltrials.gov) - Jan 12, 2016
P4, N=9, Terminated, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Completed --> Terminated | Trial primary completion date: Feb 2012 --> Feb 2009; Final cost of study medication was significantly greater than initial estimate,
- nimodipine / Generic mfg.
Enrollment open: The Effect of Nimodipine on the Postoperative Cognitive Dysfunction (clinicaltrials.gov) - Sep 30, 2015
P=N/A, N=50, Recruiting, Sponsor: University Hospital Hradec Kralove
Completed --> Terminated | Trial primary completion date: Feb 2012 --> Feb 2009; Final cost of study medication was significantly greater than initial estimate, Not yet recruiting --> Recruiting
- acetazolamide / Generic mfg., nimodipine / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage (clinicaltrials.gov) - Sep 25, 2015
P2, N=0, Withdrawn, Sponsor: University of Florida
Not yet recruiting --> Recruiting N=140 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Feb 2017 --> Sep 2015
- nimodipine / Generic mfg.
New trial: The Effect of Nimodipine on the Postoperative Cognitive Dysfunction (clinicaltrials.gov) - Sep 1, 2015
P=N/A, N=50, Not yet recruiting, Sponsor: University Hospital Hradec Kralove
- nimodipine / Generic mfg.
Enrollment closed: Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT (clinicaltrials.gov) - Jul 22, 2015
P=N/A, N=22, Active, not recruiting, Sponsor: Boston IVF
N=140 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Feb 2017 --> Sep 2015 Completed --> Active, not recruiting
- ||| nimodipine microparticles (EG-1962) / PDS Biotech
Enrollment closed: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Jun 3, 2015
P1/2, N=96, Active, not recruiting, Sponsor: Edge Therapeutics Inc
Completed --> Active, not recruiting Recruiting --> Active, not recruiting
- nimodipine / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT (clinicaltrials.gov) - May 16, 2015
P=N/A, N=22, Completed, Sponsor: Boston IVF
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=90 --> 22 | Trial primary completion date: Sep 2014 --> Apr 2014
- || nimodipine microparticles (EG-1962) / PDS Biotech
Trial primary completion date: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Apr 19, 2015
P1/2, N=96, Recruiting, Sponsor: Edge Therapeutics Inc
Active, not recruiting --> Completed | N=90 --> 22 | Trial primary completion date: Sep 2014 --> Apr 2014 Trial primary completion date: Dec 2014 --> Jul 2015
- nimodipine / Generic mfg.
Enrollment closed, Trial initiation date, Trial primary completion date: Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) - Apr 9, 2015
P2, N=90, Active, not recruiting, Sponsor: Mount Sinai Hospital, Canada
Trial primary completion date: Dec 2014 --> Jul 2015 Not yet recruiting --> Active, not recruiting | Initiation date: Jul 2012 --> Dec 2012 | Trial primary completion date: Aug 2013 --> Apr 2014
- nimodipine / Generic mfg.
Enrollment closed: Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations (clinicaltrials.gov) - Apr 7, 2015
P1, N=8, Active, not recruiting, Sponsor: University of California, San Francisco
Not yet recruiting --> Active, not recruiting | Initiation date: Jul 2012 --> Dec 2012 | Trial primary completion date: Aug 2013 --> Apr 2014 Recruiting --> Active, not recruiting
- nimodipine / Generic mfg.
Trial primary completion date: Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations (clinicaltrials.gov) - Jan 15, 2015
P1, N=8, Recruiting, Sponsor: University of California, San Francisco
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2014 --> Dec 2015
- nimodipine / Generic mfg.
Enrollment open: Nimodipine for Treating Acute Massive Cerebral Infarction (clinicaltrials.gov) - Oct 17, 2014
P4, N=72, Recruiting, Sponsor: Fengtian Hospital
Trial primary completion date: Dec 2014 --> Dec 2015 Not yet recruiting --> Recruiting
- | nimodipine / Generic mfg.
New P4 trial: Nimodipine for Treating Acute Massive Cerebral Infarction (clinicaltrials.gov) - Sep 28, 2014
P4, N=72, Not yet recruiting, Sponsor: Fengtian Hospital
- || nimodipine microparticles (EG-1962) / PDS Biotech
Trial primary completion date: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Jun 27, 2014
P1/2, N=96, Recruiting, Sponsor: Edge Therapeutics Inc
Not yet recruiting --> Recruiting Trial primary completion date: Apr 2014 --> Dec 2014
- nimodipine / Generic mfg.
Trial primary completion date: Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression (clinicaltrials.gov) - Jun 27, 2014
P4, N=9, Completed, Sponsor: University of Pittsburgh
Trial primary completion date: Apr 2014 --> Dec 2014 Trial primary completion date: Aug 2010 --> Feb 2012
- nimodipine / Generic mfg.
Enrollment change: Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression (clinicaltrials.gov) - Jun 27, 2014
P4, N=9, Completed, Sponsor: University of Pittsburgh
Trial primary completion date: Aug 2010 --> Feb 2012 N=30 --> 9
- nimodipine / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression (clinicaltrials.gov) - Jun 27, 2014
P4, N=9, Completed, Sponsor: University of Pittsburgh
N=30 --> 9 Recruiting --> Completed | N=30 --> 9 | Trial primary completion date: Aug 2010 --> Feb 2012
- | acetazolamide / Generic mfg., nimodipine / Generic mfg.
New P2 trial: Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage (clinicaltrials.gov) - Jun 18, 2014
P2, N=140, Not yet recruiting, Sponsor: University of Florida
- nimodipine / Generic mfg.
Enrollment closed: Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT (clinicaltrials.gov) - Mar 23, 2014
P=N/A, N=90, Active, not recruiting, Sponsor: Boston IVF
Recruiting --> Completed | N=30 --> 9 | Trial primary completion date: Aug 2010 --> Feb 2012 Recruiting --> Active, not recruiting
- |||| nimodipine microparticles (EG-1962) / PDS Biotech
Enrollment open: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Sep 24, 2013
P1/2, N=96, Recruiting, Sponsor: Edge Therapeutics Inc
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| nimodipine microparticles (EG-1962) / PDS Biotech
New P1/2 trial: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (clinicaltrials.gov) - Jul 4, 2013
P1/2, N=96, Recruiting, Sponsor: Edge Therapeutics Inc
- nimodipine / Generic mfg.
New P1 trial: Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations (clinicaltrials.gov) - Apr 17, 2013
P1, N=8, Recruiting, Sponsor: University of California, San Francisco
- nimodipine / Generic mfg.
Trial initiation date: Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) - Apr 18, 2012
P2, N=90, Not yet recruiting, Sponsor: Mount Sinai Hospital, Canada
Not yet recruiting --> Recruiting Initiation date: Mar 2012 --> Jul 2012
- | nimodipine / Generic mfg.
New P2 trial: Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) - Mar 8, 2012
P2, N=90, Not yet recruiting, Sponsor: Mount Sinai Hospital, Canada